Borgstrom F, Lorentzon M, Johansson H, Harvey NC, et al. Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK. Osteoporos Int 2024 Oct 4. doi: 10.1007/s00198-024-07251.
PMID: 39365433